Latest News

New study on Online Haemodiafiltration substantiates existing evidence on patient survival

scientific study icon



The new Catalonian High-Volume Online Haemodiafiltration (OL-HDF) study shows that High-Volume OL-HDF therapy improves patient’s survival rate. With a 30% reduction of all-cause mortality and 33% lower risk of cardiovascular mortality patients should benefit from High-Volume Online HDF.

Raising awareness in support of World Kidney Day

i heart my kidneys


Meet our Singapore team at Tan Tock Seng Hospital

World Kidney Day's (WKD) aim is to raise awareness of the importance of the kidneys to the overall health of the population and to reduce the frequency and impact of kidney disease and its associated health problems worldwide. WKD is a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF).

Welcome to Fresenius Medical Care Connect – your quick connection to our renal news!

newsletter thumb1



Welcome to Fresenius Medical Care (FME) Connect, your new quarterly e-newsletter! We want to update you on a variety of renal topics ranging from the latest scientific news to our company product updates and worldwide renal events.

A global renal healthcare leader launches their new headquarters in Singapore

fresenius logo



Fresenius Medical Care strengthens its ties within Asia

The world’s largest renal healthcare company, Fresenius Medical Care (FME) recently established its new South Asia Pacific headquarters in Singapore. The regional headquarters is responsible for operations in Singapore, Malaysia, Indonesia, Australia, New Zealand and the surrounding islands.

Fresenius – celebrating 100 years of patient care

100 years


Fresenius, the global healthcare company, celebrates its 100th anniversary in 2012. The Fresenius Group offers products and services for dialysis, the hospital and the medical care of patients at home with its four business segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.